Anthem-Cigna merger most likely dead

The largest healthcare merger ever proposed likely drew its dying breath on Friday, as the U.S. Court of Appeals for the D.C. Circuit affirmed lower court rulings that blocked the deal on antitrust grounds. While the ruling was appealed in February, the chances of a successful argument were slim, according to policy analysts.

The appeals court ruled the deal would have reduced competition, rejecting Anthem's argument that the merger would proivide savings for health insurance customers. 

"Anthem has not explained why these projected savings would even exist," Judge Judith Rogers wrote. "The record is clear that Anthem, unlike Cigna, has already achieved whatever economies of scale are available."

Further compllicating matters are dueling lawsuits in the wake of the failed merger: both Anthem and Cigna are suing each other. Cigna sought to terminate the merger, while Anthem sought a restrining order to block Cigna from doing just that.

Read more below:

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.